Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

People Strong - Innovation Driven

BWXT Canada Joins the Canadian Nuclear Isotope Council

BWXT Canada Ltd. (BWXT Canada) has joined the Canadian Nuclear Isotope Council (CNIC) – an independent organization which advocates for Canada’s role in the production of the world’s supply of radioisotopes.

The CNIC, which is made up of 18 organizations from various levels within the Canadian health sector, nuclear industry and research bodies, will work together to foster innovation and ensure Canada remains at the forefront of radioisotope production.

“Ensuring the availability of and access to radioisotopes is a cause we are extremely passionate about,” said President, BWXT Canada, John MacQuarrie. “Radioisotopes play a critical role in our everyday lives, whether for diagnosis and treatment of disease to the sterilization of medical equipment and consumer goods. BWXT Canada is proud to be part of this team of experts who will work together to ensure Canada continues to be a leader in this critical space.”

In April, BWXT Canada’s parent company, BWX Technologies, Inc. (BWXT), announced it had signed a definitive agreement to acquire Sotera Health’s Nordion medical isotope business, which is based in Canada. Subject to required Canadian and U.S. regulatory reviews and approvals, the acquisition is expected to close by the end of 2018.